HF/Transplantation

Top Story

Intra-aortic balloon pumps voluntarily recalled after patient death

June 20, 2017

The FDA issued a safety alert announcing that Datascope Corp. issued a voluntary field correction for intra-aortic balloon pumps due to a potential electrical test failure code.

The test failure code in the intra-aortic balloon pumps (CS100, CS100i, CS300, System 98 or System 98XT converted to CS 100i or CS300) has resulted in one patient death due to failure to initiate therapy. The reported death was related to a CS300 intra-aortic balloon pump with codes for autofill failure, failure to power vent and maintenance.

In the JournalsPerspective

Patients with ICDs may engage in sports

June 19, 2017
Many patients with implantable cardioverter defibrillators can participate in vigorous sports, according to a research letter in Circulation. “Our data
In the Journals

Select traditional Chinese medicine may benefit patients with heart disease

June 16, 2017
Unmet needs in Western medicine have made traditional Chinese medicine a more common alternative for primary and secondary CVD prevention, but more randomized trials of…
In the Journals

Outcomes differ in patients with acute HF based on systolic BP, clinical profile

June 16, 2017
Adverse outcomes differed in patients with acute HF based on systolic BP and clinical profile at admission, although variances were reduced up to 6 months after…
FDA News

Intra-aortic balloon pumps voluntarily recalled after patient death

June 20, 2017
The FDA issued a safety alert announcing that Datascope Corp. issued a voluntary field correction for intra-aortic balloon pumps due to a potential

In the JournalsPerspective

Patients with ICDs may engage in sports

June 19, 2017
Many patients with implantable cardioverter defibrillators can participate in vigorous sports, according to a research letter in Circulation

In the Journals

Select traditional Chinese medicine may benefit patients with heart disease

June 16, 2017
Unmet needs in Western medicine have made traditional Chinese medicine a more common alternative for primary and secondary CVD prevention, but more…

In the Journals

Outcomes differ in patients with acute HF based on systolic BP, clinical profile

June 16, 2017
Adverse outcomes differed in patients with acute HF based on systolic BP and clinical profile at admission, although variances were reduced up to 6…

In the Journals

Alcohol ablation viable in younger patients with obstructive hypertrophic cardiomyopathy

June 15, 2017
New data demonstrate that alcohol septal ablation is safe and effective for symptom relief in younger patients with obstructive hypertrophic…

Meeting News

Cardiopoietic stem cells may confer reverse LV remodeling in HF

June 15, 2017
Intramyocardial administration of cardiopoietic stem cells in patients with advanced HF prompted significant reverse left ventricular remodeling…

In the JournalsPerspective

Intensive BP lowering may reduce risk for LV hypertrophy

June 13, 2017
Intensive BP-lowering therapy for patients with hypertension who do not have diabetes reduced the risk for left ventricular hypertrophy or regressed…

Meeting News

AUGMENT-HF: Implant procedure continues to benefit patients with HF

June 12, 2017
Patients with advanced HF treated with an implant procedure in addition to standard medical therapy had long-term benefits, according to results…

Readmission to original hospital confers better outcomes in patients with HF

June 9, 2017
Patients with HF who are readmitted to the same hospital had improved outcomes compared with those admitted to a different hospital, according to a…

In the Journals

Risk for incident HF may be higher in postmenopausal women

June 9, 2017
Postmenopausal women with a shorter total reproductive period had a higher risk for incident HF, and those who had never given birth had increased…

More Headlines »
Advertisement
Advertisement